Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection

British Journal of Surgery

Volumn 99, Issue 10, 2012, Pages 1396-1405

  Van Der Ploeg, A P T ^a   Van Akkooi, A C J ^a   Rutkowski, P ^c   Cook, M ^d   Nieweg, O E ^b   Rossi, C R ^e   Testori, A ^f   Suciu, S ^g   Verhoef, C ^a   Eggermont, A M M ^h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF PADOVA   (Italy)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^g EORTC DATA CENTER   (Belgium)

^h INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MELANOMA; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; SURVIVAL;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84866106539     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8878     Document Type: Article

References (32)

1. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al., Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317.
2. Kingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG,. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. Ann Surg Oncol 2010; 17: 514-520.
3. Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, et al., Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol 2006; 13: 809-816.
4. van der Ploeg AP, van Akkooi AC, Rutkowski P, Nowecki ZI, Michej W, Mitra A, et al., Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol 2011; 29: 2206-2214.
5. Starz H, Siedlecki K, Balda BR,. Sentinel lymphonodectomy and S-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004; 11 (Suppl): 162S-18S.
6. van Akkooi AC, Nowecki Z, Voit C, Schäfer-Hesterberg G, Michej W, de Wilt JH, et al., Minimal sentinel node (SN) tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients. A multicenter study in 388 SN positive patients. Ann Surg 2008; 248: 949-955.
7. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG,. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004; 22: 3345-3349.
8. Govindarajan A, Ghazarian DM, McCready DR, Leong WL,. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 2007; 14: 906-912.
9. van Akkooi AC, de Wilt JH, Verhoef C, Schmitz PI, van Geel AN, Eggermont AM, et al., Clinical relevance of melanoma micrometastases (< 0·1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 2006; 17: 1578-1585.
10. van der Ploeg AP, van Akkooi AC, Schmitz PI, Koljenovic S, Verhoef C, Eggermont AM,. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria. Eur J Cancer 2010; 46: 2414-2421.
11. van der Ploeg IM, Kroon BB, Antonini N, Valdés Olmos RA, Nieweg OE,. Is completion lymph node dissection needed in case of minimal melanoma metastasis in the sentinel node? Ann Surg 2009; 249: 1003-1007.
12. van der Ploeg IM, Kroon BB, Antonini N, Valdés Olmos RA, Nieweg OE,. Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node. Ann Surg 2009; 250: 301-314.
13. Elias N, Tanabe KK, Sober AJ, Gadd MA, Mihm MC, Goodspeed B, et al., Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg 2004; 139: 400-404.
14. McMasters KM,. Why does no one want to perform lymph node dissection anymore? Ann Surg Oncol 2010; 17: 358-361.
15. Morton DL, Scheri RP, Balch CM,. Can completion lymph node dissection be avoided for a positive sentinel node in melanoma? Ann Surg Oncol 2007; 14: 2437-2439.
16. Murali R, Desilva C, Thompson JF, Scolyer RA,. Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. J Clin Oncol 2010; 28: 4441-4449.
17. Scheri RP, Essner R, Turner RR, Ye X, Morton DL,. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 2007; 14: 2861-2866.
18. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al., Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
19. Uren RF, Thompson JF, Howman-Giles R,. Sentinel lymph node biopsy in patients with melanoma and breast cancer. Intern Med J 2001; 31: 547-553.
20. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, et al., Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
21. Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN,. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993; 2: 303-308.
22. Cook MG, Green MA, Anderson B, Eggermont AM, Ruiter DJ, Spatz A, et al.,; EORTC Melanoma Group. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003; 200: 314-319.
23. Collett D,. Modelling Survival Data in Medical Research (2nd edn). Chapman & Hall/CRC: Boca Raton, 2003.
24. Bilimoria KY, Balch CM, Bentrem DJ, Talamonti MS, Ko CY, Lange JR, et al., Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol 2008; 15: 1566-1576.
25. Faries MB, Thompson JF, Cochran A, Elashoff R, Glass EC, Mozzillo N, et al.,; MSLT Cooperative Group. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol 2010; 17: 3324-3329.
26. Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, et al., Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malginant melanoma. Ann Surg 2008; 247: 687-693.
27. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, et al.,; Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302-311.
28. van Akkooi AC, Bouwhuis MG, van Geel AN, Hoedemaker R, Verhoef C, Grunhagen DJ, et al., Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 2007; 33: 102-108.
29. Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, et al.,; Sunbelt Melanoma Trial Study Group. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003; 10: 676-680.
30. de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ,. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol 2006; 32: 785-789.
31. de Vries M, Hoekstra HJ, Hoekstra-Weebers JE,. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol 2009; 16: 2840-2847.
32. Henderson MA,. Completion lymphadenectomy for melanoma patients with a positive sentinel node biopsy remains standard of care. Ann Surg Oncol 2006; 13: 761-763.